Establishment of Zhongtai Biotechnology (Dalian) R&D Base

On March 1, 2025, “Zhongtai Biotechnology (Dalian) Co., Ltd.”and “Ciming Aoya Hospital (Dalian) Co., Ltd.”jointly established an R&D base in Dalian.  

Wang Xian,General Manager of Dalian Yuanxin Company,attended the ceremony as an investment shareholder. The event also invited experts from China's medical and health supplement industries, who expressed recognition and support for Zhongtai Biotechnology's products in promoting wellness and medical applications.  

With the new R&D base and existing company laboratories, Zhongtai Biotechnology will further advance its research, benefiting both the nation and its people, and contributing to the country's healthcare development.